Specialistuddannelse for Klinisk laboratoriegenetiker

Målbeskrivelsen findes her (link)

Sådan søger du (fil)

Blanket til ansøgning om optagelse (fil)

Blanket til ansøgning om optagelse-2 (fil)

Ansøgningsskema, afsluttet uddannelse (fil)

Uddannelseslog (fil)

Uddannelsesplan (fil)

Kompetencekort for Klinisk Laboratoriegenetiker

Uddannelseudvalg

Charlotte Brasch Andersen, Formand
Helena Gásdal Karstensen
Inge Søkilde Pedersen
Jesper Graakjær
Rikke Christensen
Thomas Blauenfeldt

Uddannelsesansvarlige

Aalborg universitet, Afsnit for Molekylær diagnostik:
Klinisk laboratoriegenetiker Inge Søkilde Pedersen (ErCLG)

Aarhus Universitetshospital, Klinisk Genetisk afd.:
Klinisk laboratoriegenetiker Rikke Christensen (KLG)

Sygehus Lillebælt, Klinisk Genetisk afd.:
Klinisk laboratoriegenetiker Jesper Graakjær (ErCLG)

Odense Universitetshospital, Klinisk Genetisk afd.:
Klinisk laboratoriegenetiker Charlotte Brasch Andersen (ErCLG)

Rigshospitalet, Klinisk Genetisk Klinik:
Klinisk laboratoriegenetiker Helena Gásdal Karstensen

juli 2026

22julAll Day23Connect CACNA1C Global Network Conference

august 2026

25augAll Day26Gene Forum - 25th anniversary conference

september 2026

05sepAll Day09European Epilepsy Congress

07sepAll Day11Basics in human genetic diagnostics – A course for CLGs in education

13sepAll Day16EUFASD Conference 2026

Event detaljer

Fetal Alcohol Spectrum Disorders (FASD) are a major public health problem worldwide: alcohol consumption during pregnancy is one of the leading non-genetic and potentially preventable causes of neurodevelopmental disorders (NDDs) and lack of social integration.

In France, for example, it is estimated that nearly 5,000 children are born each year with brain damage due to prenatal alcohol exposure. Rarely screened and then underdiagnosed, these particularly vulnerable children will face disabilities both at school and in everyday life. In adulthood, around 500,000 people are affected to varying degrees. Most of them are unaware of the cause of their troubles and do not receive any specific support, with considerable individual and collective human costs.

However, early detection, diagnosis, and appropriate support starting in early childhood can make a difference and enable each of these people to develop their full potential for a better integration and participation in society.

Awareness of FASD is poor among the general public and even among healthcare professionals, who need an improved training on the subject. Furthermore, fundamental and clinical research is essential to bring about change in FASD and other NDDs: but here again, investment is not in line with the challenges.

In this context, the EUFASD 2026 Conference is an exceptional opportunity at the European level to highlight the issue of FASD and to support objectives aiming at structuring the community of associations, healthcare and support professionals, as well as researchers.

More information